According to Legend Biotech's latest financial reports the company has $1.30 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $1.02 B | 16.23% |
2021-12-31 | $0.88 B | 74.49% |
2020-12-31 | $0.50 B | 218.2% |
2019-12-31 | $0.15 B | -26.49% |
2018-12-31 | $0.21 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | -84.09% | ๐บ๐ธ USA |